Literature DB >> 32412914

Using Telemedicine During the COVID-19 Pandemic.

Vidushi Mahajan1, Tanvi Singh2, Chandrika Azad2.   

Abstract

Telemedicine is the delivery of health care services using information or communication technology. In the current pandemic scenario, telemedicine can supplement health-care delivery in the absence of in-person visit. The Government of India has recently launched the e-sanjeevani OPD, a National teleconsultation service, which has been adopted by many state governments as mandatory for health-care providers. With Indian Medical Association issuing an advisory against the use of telemedicine except in few situations, a lot of confusion exists in the mind of a pediatrician. Despite the uncertain situation, we have to remember that other diseases shall not stall in the face of a pandemic. Since telemedicine is an evolving subject, training of medical professionals, clear guidelines and good quality internet service systems will go a long way in increasing the acceptability of telemedicine in the Indian population. We herein discuss issues related to using telemedicine during the SARS-CoV-2 pandemic.

Entities:  

Mesh:

Year:  2020        PMID: 32412914

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  23 in total

1.  Managing Children with Special Needs in COVID-19 Times.

Authors:  Monica Juneja; Arpita Gupta
Journal:  Indian Pediatr       Date:  2020-07-24       Impact factor: 1.411

2.  Diagnosis of COVID-19, vitality of emerging technologies and preventive measures.

Authors:  Muhammad Asif; Yun Xu; Fei Xiao; Yimin Sun
Journal:  Chem Eng J       Date:  2021-05-07       Impact factor: 13.273

3.  Telemedicine During the COVID-19 Pandemic: A Paradigm Shift in Non-Communicable Disease Management? - A Cross-Sectional Survey from a Quaternary-Care Center in South India.

Authors:  Sisira Ullas; Manu Pradeep; Sandeep Surendran; Anjali Ravikumar; Anna Maria Bastine; Ayush Prasad; Aravind Mohan
Journal:  Patient Prefer Adherence       Date:  2021-12-08       Impact factor: 2.711

4.  Experience of Telemedicine in Gastroenterology Out-Patient Practice During the COVID-19 Pandemic: Experiences from a Tertiary-Care Hospital in a Developing Country.

Authors:  Anjiya Shaikh; Maria Khan; Faisal Waseem Ismail
Journal:  Clin Exp Gastroenterol       Date:  2022-06-17

5.  How the COVID-19 Pandemic Experience has Affected Pediatric Palliative Care in Mumbai.

Authors:  Pradnya Talawadekar; Smriti Khanna; Veronique Dinand; Prakash Fernandes; Jayita Deodhar; Mary Ann Muckaden
Journal:  Indian J Palliat Care       Date:  2020-06-30

6.  Face-to-face Video Interview as an Alternative to In-person Visit to a Neonatal Intensive Care Unit during COVID-19 Outbreak.

Authors:  Hyun Ho Kim; Dae Sun Jo; Jin Kyu Kim
Journal:  J Korean Med Sci       Date:  2020-12-07       Impact factor: 2.153

7.  Telemedicine in the Era of COVID-19 and Beyond: A new horizon.

Authors:  Hussain Alsaffar; Watfa Almamari; Amna Al Futaisi
Journal:  Sultan Qaboos Univ Med J       Date:  2020-12-21

Review 8.  The Impact of the COVID-19 Pandemic and the Importance of Telemedicine in Managing Acute ST Segment Elevation Myocardial Infarction Patients: Preliminary Experience and Literature Review.

Authors:  Jing Nan; Ruofei Jia; Shuai Meng; Yubo Jin; Wei Chen; Hongyu Hu
Journal:  J Med Syst       Date:  2021-01-03       Impact factor: 4.460

9.  Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.

Authors:  Jing Nan; Shuai Meng; Hongyu Hu; Ruofei Jia; Wei Chen; Qun Li; Tong Zhang; Ke Song; Yang Wang; Zening Jin
Journal:  Med Sci Monit       Date:  2020-09-17

10.  Telephonic Triage and Telemedicine During the Peak of COVID-19 Pandemic - Restricting Exposure to Healthcare Professionals.

Authors:  Aliza Mittal; Puneet Pareek
Journal:  Indian Pediatr       Date:  2020-08-11       Impact factor: 3.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.